Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Prof. Dr. Dr. h.c. Christoph Lange

Breadcrumb

  1. Home
  2. About Us
  3. Staff
  4. Prof. Dr. Dr. H.c. Christoph Lange
Contact
Christoph Lange

Prof. Dr. Dr. h.c. Christoph Lange

Telefonnummer +49 4537 188 3320
E-Mail Send mail
Partner Site
Hamburg - Lübeck - Borstel - Riems
Institution
Research Center Borstel Leibniz Lung Center
Research Area
Tuberculosis
Infrastructure
Clinical Trial Unit

Research of the employee

Hamburg - Lübeck - Borstel - Riems

Eastern European Study Site

As part of a partnership, the so-called Eastern European Study Site (EESS) was set up in Bucharest (Romania) with the Marius-Nasta Institute and the affiliated tuberculosis hospital. Eastern European countries have a high occurrence of tuberculosis, and the number of multiresistant TB cases is especially high. In Bucharest, it is [...]

Read more
Hamburg - Lübeck - Borstel - Riems

Clinical Tuberculosis Center

The Clinical Tuberculosis Center provides the expertise and infrastructure for the optimization, prevention, diagnosis, and treatment of tuberculosis (TB) as well as for translating research results into clinical practice. The main objectives of the Clinical Tuberculosis Center include coordinating clinical research activities involving the DZIF TB cohort. This cohort includes [...]

Read more

Publications of the employee

Jun 2024
Pathog Immun

A Transcriptomic Biomarker Predicting Linezolid-Associated Neuropathy During Treatment of Drug-Resistant Tuberculosis

Autoren
Zielinski N et al.
Go to publication
Jun 2024
J Infect

Clinical spectrum and relevance of Mycobacterium malmoense: Systematic review and meta-analysis of 859 patients

Autoren
Wetzstein N et al.
Go to publication
Jun 2024
Clin Microbiol Infect

Availability of drugs and resistance testing for bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaL(M)) regimen for rifampicin-resistant tuberculosis in Europe: author's response

Autoren
Lange C et al.
Go to publication
May 2024
Pneumologie

[Everything under control?]

Autoren
Eggeling J et al.
Go to publication
May 2024
Lancet Microbe

Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles

Autoren
Gillespie SH et al.
Go to publication
May 2024
Lancet Respir Med

Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studies

Autoren
Martinez L et al.
Go to publication
Sep 2023
Clin Microbiol Infect

Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard

Autoren
Salzer HJF et al.
Go to publication
All publications
  • Share on
    • LinkedIn
Print

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Education and Research and the participating federal states